Stuart Poulton - Net Worth and Insider Trading
Stuart Poulton Net Worth
The estimated net worth of Stuart Poulton is at least $276,229 dollars as of 2024-11-06. Stuart Poulton is the EVP, Chief Development Officer of Karyopharm Therapeutics Inc and owns about 326,628 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $276,229. Details can be seen in Stuart Poulton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stuart Poulton has not made any transactions after 2024-07-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stuart Poulton
Stuart Poulton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stuart Poulton owns 1 companies in total, including Karyopharm Therapeutics Inc (KPTI) .
Click here to see the complete history of Stuart Poulton’s form 4 insider trades.
Insider Ownership Summary of Stuart Poulton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2024-07-30 | EVP & Chief Development Officer |
Stuart Poulton Latest Holdings Summary
Stuart Poulton currently owns a total of 1 stock. Stuart Poulton owns 326,628 shares of Karyopharm Therapeutics Inc (KPTI) as of July 30, 2024, with a value of $276,229.
Latest Holdings of Stuart Poulton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2024-07-30 | 326,628 | 0.85 | 276,229 |
Holding Weightings of Stuart Poulton
Stuart Poulton Form 4 Trading Tracker
According to the SEC Form 4 filings, Stuart Poulton has made a total of 4 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 2,883 shares on July 30, 2024, which brought Stuart Poulton around $3,056.
Insider Trading History of Stuart Poulton
- 1
Stuart Poulton Trading Performance
Stuart Poulton Ownership Network
Ownership Network List of Stuart Poulton
Ownership Network Relation of Stuart Poulton
Stuart Poulton Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Stuart Poulton is the EVP & Chief Development Officer of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include director & President and CEO Richard A. Paulson , EVP & CFO & Treasurer Michael Mason , and SVP & General Counsel&Secretary Michael Mano .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Stuart Poulton made 4 insider transaction in Karyopharm Therapeutics Inc (KPTI) with a net sale of 34,041. Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 162,007 shares made by Richard A. Paulson , a net sale of 55,845 shares made by Michael Mason , and a net sale of 41,559 shares made by Sohanya Roshan Cheng .
In summary, during the past 3 months, insiders sold 23,651 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 23,651 shares. During the past 18 months, 2,074,507 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 2,033,367 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Stuart Poulton Mailing Address
Above is the net worth, insider trading, and ownership report for Stuart Poulton. You might contact Stuart Poulton via mailing address: 85 Wells Avenue, Newton Ma 02459.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
